About Hypervision Surgical
Hypervision Surgical Ltd is a King's College London spin-out founded by a team of clinicians, medical imaging and artificial intelligence experts. The company has developed a surgical imaging and data analytics platform that uses AI-powered hyperspectral imaging to make surgeries more precise, safer and faster. Their technology addresses a critical clinical need: providing surgeons with objective, real-time tissue information during operations to improve surgical precision and patient safety. The system uses safe light alone—no contrast agents required—to provide quantitative, wide-field information on physiological tissue properties including perfusion assessment and tissue differentiation. By splitting light into multiple spectral bands far beyond conventional RGB colours, their hyperspectral imaging carries diagnostic information ideal for objective tissue characterisation. The platform is capable of AI-driven, wide-field tissue differentiation to identify tumour, normal tissue, nerves and blood vessels in real time. This technology is particularly valuable in neurosurgery, where complete tumour removal must be balanced with healthy tissue preservation to minimise neurological impairment. The company's approach is non-contact, non-invasive, and seamlessly integrates into surgical workflow. Hypervision Surgical raised £6.5 million in seed funding in 2023 and appointed Martin Frost CBE, founder of CMR Surgical, as Chairman to accelerate commercialisation efforts.
Mission & Story
Mission
Our goal is to equip clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety
Founding Story
Hypervision Surgical was formed as a spin-out from King's College London, founded by a team of clinicians, medical imaging and artificial intelligence experts including Michael Ebner (CEO), Tom Vercauteren (Professor of Interventional Image Computing), Sébastien Ourselin (Chair of Healthcare Engineering), and Jonathan Shapey (Consultant neurosurgeon)
Clinical Focus
Medical conditions and clinical areas addressed by Hypervision Surgical.
Who It Serves
Milestones & Awards
Recent Milestones
Raised £6.5 million oversubscribed seed funding in June 2023. Appointed Martin Frost CBE (founder of CMR Surgical) as Chairman in September 2023. Presented technology at NVIDIA GTC 2022 keynote.
Awards & Recognition
Royal Academy of Engineering Enterprise Fellowship (CEO Michael Ebner). Medtronic/RAEng Research Chair in Machine Learning for Computer-Assisted Neurosurgery (CSO Tom Vercauteren). Martin Frost CBE awarded CBE in 2020 Queen's Birthday Honours.
Key Partnerships
Social & Media
Latest Updates
From Seed to Series A: Hypervision Surgical at LSI Europe in London
Hypervision Surgical Raises £17 Million Series A to Power Surgical Intelligence Through Hyperspectral Vision
Hypervision Surgical receives FDA Clearance for HYPERSNAP® Surgical System to improve patient safety
Hypervision Surgical Wins the Lippmann Award at IEEE WHISPERS Conference
From Plenary Spotlight to Shark Tank Success: Hypervision Surgical at SRS 2025
Company Details
- Founded
- 2020
- Headquarters
- London, England, United Kingdom
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingMarket
Surgical AI & RoboticsOfficial Sources
Similar Companies in this Market
View all 58 →
3D-Side
AI-powered 3D preoperative planning and patient-specific medical devices for surgical workflow optimization and planning.
Activ Surgical
series b · 40 employees
Activ Surgical provides intraoperative surgical intelligence enabling surgeons to view critical physiological structures and functions in real-time.
AIbolit Technologies
Aibolit Technologies (Aibo Health) provides an AI- and AR-powered perioperative digital platform that optimizes operating room workflows, enhances surgical quality, and improves training for nurses, surgeons, and OR managers across hospitals and ambulatory surgery centers.
Asensus Surgical
Asensus Surgical develops robotic-assisted surgical systems integrated with Augmented Intelligence to provide real-time insights during minimally invasive procedures. The company's Senhance® Surgical System and Intelligent Surgical Unit™ deliver data-driven decision support to surgeons, enhancing precision, efficiency, and patient outcomes.
Augmedics
Augmedics develops augmented reality surgical navigation technology for spine surgery. Their xvision Spine System provides surgeons with x-ray vision through AR headsets, enabling them to visualize patient anatomy in 3D during procedures without looking away at screens.
Augmedit
11-50 employees
Augmedit develops augmented reality medical software that guides surgeons through complex procedures using 3D holograms generated from medical imaging. The company's platform converts 2D DICOM images into interactive 3D models for surgical planning, patient education, and intra-operative visualization.
Brainlab
Brainlab develops hardware and software technology for surgery and radiation therapy to help healthcare providers, physicians and their patients fight cancer and other conditions of the brain and body.
Caranx Medical
Caranx Medical develops surgical AI and robotics solutions for healthcare providers. The company focuses on advancing surgical precision and outcomes through innovative technology platforms.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.